Professional practices and perception towards rational use of medicines according to WHO methodology in United Arab Emirates
Inappropriate prescribing reduces the quality of medical care and leads to a waste of resources. No study has been reported concerning rational drug use in United Arab Emirates, UAE, recently.
Objectives: 1. assessing patterns of use and defining problems regarding the rational drug use. 2. Setting baseline situational analysis study for practices in the health care system relevant to drug use.
Method: A descriptive pilot study, consisting of pharmacists, physicians and patients (100 of each of category) from four private hospitals, (12) medical clinics, (80) community pharmacies in addition to 150 prescriptions. A questionnaire of three sections was designed to include WHO indicators regarding patients, facility and prescribing patterns that are relevant to rational drug use was carried out in four emirates of the UAE in the period December 2008-Febreuary 2009.
Results: Consultation and dispensing times were 10 (SD=2.75) min and 68 (SD=9.7) seconds, respectively. Average no. of drugs per prescription was (2.9 + 0.97), % of prescriptions using generic name (7.35%), % of antibiotic containing prescriptions (31.1%), % of injection containing prescriptions (2.9%), adherence to Standard Treatment Protocols (46%), adherence to the essential drug list (64%), patient’s knowledge of correct dosage (55%), adequately labeled drugs (45%), patient’s information (65%).
Conclusions: Several areas of deficiency in rational drug use had been defined in the private sector through UAE that can be remedied through adopting several strategies such as adherence to national standard treatment guidelines and essential drug list based on treatments of choice, interaction between health care system and providing drugs information to consumers.
2. Promoting rational use of medicines: core components. WHO policy perspectives on medicines. Geneva, World Health Organization. No. (WHO/EDM/2002.3), 2002.
3. WHO medicines strategy: framework for action in essential drugs and medicines policy 2000-2003. Geneva, World Health Organization." No. (WHO/EDM/2000.1), 2002.
4. How to investigate drug use in health facilities (Selected drug use indicators). Action Program on Essential Drugs, World Health Organization, Geneva." 1995.
5. Vahn Lewis. How to write a prescription. The University of Texas (2009) Online. Available at http://www.db.uth.tmc.edu/faculty/vlewis/Vahnspage/2561/RXWritingRefs.htm
6. Otoom SA, Sequeira RP. Health care providers' perceptions of the problem and causes of irrational use of drugs in two middle east countries. Int J Clin Pract. 2006,60(5):565-570.
7. Hasan MY, Das M, Mourad F. Drug utilization and antibiotic use in the PHC centers in Sharjah. Eastern Mediterranean Health J. 1997;3(3);444-451.
8. Deveugele M, Derese A, Brink-Muinen A, Bensing J, Maeseneer JD. Consultation length in general practice: cross sectional study in Six European countries. 2002. BMJ 2002;325,472.
9. Otoom S, Batieha H, Hadidi M, Al-Saudi K. Evaluation of drug use in Jordan using WHO patient care and health facility indicators. Eastern Mediterranean Health J. 2002;8,(4-5).
10. Sharif SI, Al-Shaqra M, Hajjar H, Shamout A, Wess L. Patterns of drug prescribing in a hospital in Dubai, United Arab Emirates. Libyan J Med. 2007;AOP:070928,1-4.
11. Hamadeh GN, Dickerson LM, Saab BR, Major SC. Common prescriptions in ambulatory care in Lebanon. Ann Pharmacother. 2001;35,(5);636-640.
The authors hereby transfer, assign, or otherwise convey to Pharmacy Practice: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print pr epublish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to Pharmacy Practice with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.